Literature DB >> 20361198

TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.

Eileen H Bigio1, Manjari Mishra, Kimmo J Hatanpaa, Charles L White, Nancy Johnson, Alfred Rademaker, Bing Bing Weitner, Han-Xiang Deng, Steven D Dubner, Sandra Weintraub, Marsel Mesulam.   

Abstract

The clinical syndrome of primary progressive aphasia (PPA) can be associated with a variety of neuropathologic diagnoses at autopsy. Thirty percent of cases have Alzheimer disease (AD) pathology, most often in the usual distribution, which defies principles of brain-behavior organization, in that aphasia is not symptomatic of limbic disease. The present study investigated whether concomitant TDP-43 pathology could resolve the lack of clinico-anatomic concordance. In this paper, 16 cases of clinical PPA and 10 cases of primarily non-aphasic frontotemporal dementia (FTD), all with AD pathology, were investigated to determine whether their atypical clinical phenotypes reflected the presence of additional TDP-43 pathology. A comparison group consisted of 27 cases of pathologic AD with the typical amnestic clinical phenotype of probable AD. Concomitant TDP-43 pathology was discovered in only three of the FTD and PPA but in more than half of the typical amnestic clinical phenotypes. Hippocampal sclerosis (HS) was closely associated with TDP-43 pathology when all groups were combined for analysis. Therefore, the clinical phenotypes of PPA and FTD in cases with pathologic AD are only rarely associated with TDP-43 proteinopathy. Furthermore, medial temporal TDP-43 pathology is more tightly linked to HS than to clinical phenotype. These findings challenge the current notions about clinicopathologic correlation, especially about the role of multiple pathologies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20361198      PMCID: PMC2903745          DOI: 10.1007/s00401-010-0681-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  44 in total

1.  Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.

Authors:  Shinji Higashi; Eizo Iseki; Ryoko Yamamoto; Michiko Minegishi; Hiroaki Hino; Koshiro Fujisawa; Takashi Togo; Omi Katsuse; Hirotake Uchikado; Yoshiko Furukawa; Kenji Kosaka; Heii Arai
Journal:  Brain Res       Date:  2007-10-25       Impact factor: 3.252

2.  Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.

Authors:  Felix Geser; Matthew J Winton; Linda K Kwong; Yan Xu; Sharon X Xie; Lionel M Igaz; Ralph M Garruto; Daniel P Perl; Douglas Galasko; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2007-08-23       Impact factor: 17.088

3.  Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease.

Authors:  William T Hu; Keith A Josephs; David S Knopman; Bradley F Boeve; Dennis W Dickson; Ronald C Petersen; Joseph E Parisi
Journal:  Acta Neuropathol       Date:  2008-07-01       Impact factor: 17.088

4.  Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.

Authors:  K A Josephs; J L Whitwell; J R Duffy; W A Vanvoorst; E A Strand; W T Hu; B F Boeve; N R Graff-Radford; J E Parisi; D S Knopman; D W Dickson; C R Jack; R C Petersen
Journal:  Neurology       Date:  2008-01-01       Impact factor: 9.910

5.  TAR-DNA binding protein 43 in Pick disease.

Authors:  Stefanie H Freeman; Tara Spires-Jones; Bradley T Hyman; John H Growdon; Matthew P Frosch
Journal:  J Neuropathol Exp Neurol       Date:  2008-01       Impact factor: 3.685

6.  Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.

Authors:  Kunihiro Uryu; Hanae Nakashima-Yasuda; Mark S Forman; Linda K Kwong; Christopher M Clark; Murray Grossman; Bruce L Miller; Hans A Kretzschmar; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

7.  Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.

Authors:  K A Josephs; J L Whitwell; D S Knopman; W T Hu; D A Stroh; M Baker; R Rademakers; B F Boeve; J E Parisi; G E Smith; R J Ivnik; R C Petersen; C R Jack; D W Dickson
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

8.  Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.

Authors:  Marsel Mesulam; Alissa Wicklund; Nancy Johnson; Emily Rogalski; Gabriel C Léger; Alfred Rademaker; Sandra Weintraub; Eileen H Bigio
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

9.  TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study.

Authors:  Kimmo J Hatanpaa; Eileen H Bigio; Nigel J Cairns; Kyle B Womack; Sandra Weintraub; John C Morris; Chan Foong; Guanghua Xiao; Christa Hladik; Tina Y Mantanona; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

Review 10.  Hippocampal sclerosis dementia: a reappraisal.

Authors:  Alphonse Probst; Kirsten I Taylor; Markus Tolnay
Journal:  Acta Neuropathol       Date:  2007-07-17       Impact factor: 17.088

View more
  40 in total

1.  Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.

Authors:  John L Robinson; Felix Geser; Maria M Corrada; Daniel J Berlau; Steven E Arnold; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

2.  TDP-43 is a key player in the clinical features associated with Alzheimer's disease.

Authors:  Keith A Josephs; Jennifer L Whitwell; Stephen D Weigand; Melissa E Murray; Nirubol Tosakulwong; Amanda M Liesinger; Leonard Petrucelli; Matthew L Senjem; David S Knopman; Bradley F Boeve; Robert J Ivnik; Glenn E Smith; Clifford R Jack; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-03-23       Impact factor: 17.088

3.  Asymmetric TDP pathology in primary progressive aphasia with right hemisphere language dominance.

Authors:  Garam Kim; Shahrooz Vahedi; Tamar Gefen; Sandra Weintraub; Eileen H Bigio; Marek-Marsel Mesulam; Changiz Geula
Journal:  Neurology       Date:  2018-01-05       Impact factor: 9.910

Review 4.  Making the diagnosis of frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  Arch Pathol Lab Med       Date:  2013-03       Impact factor: 5.534

5.  TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Authors:  Anil Varma V Vatsavayi; Julia Kofler; Mary Ann A Demichele-Sweet; Patrick S Murray; Oscar L Lopez; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2014-03-04       Impact factor: 3.878

Review 6.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

7.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

8.  Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus.

Authors:  Stefan J Teipel; Wilhelm Flatz; Nibal Ackl; Michel Grothe; Ingo Kilimann; Arun L W Bokde; Lea Grinberg; Edson Amaro; Vanja Kljajevic; Eduardo Alho; Christina Knels; Anne Ebert; Helmut Heinsen; Adrian Danek
Journal:  Psychiatry Res       Date:  2013-12-06       Impact factor: 3.222

9.  Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features.

Authors:  Emily Rogalski; Jaiashre Sridhar; Benjamin Rader; Adam Martersteck; Kewei Chen; Derin Cobia; Cynthia K Thompson; Sandra Weintraub; Eileen H Bigio; M-Marsel Mesulam
Journal:  Neurology       Date:  2016-08-26       Impact factor: 9.910

Review 10.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.